Ellsworth Advisors »

Arcutis Biotherapeutics shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $788k 30k 26.36

More positions owned by Ellsworth Advisors

Spdr Gold Tr Gold Shs (GLD)
NVIDIA Corporation (NVDA)
Harbor Etf Trust Harbor Commodity (HGER)
First Tr Exchange-traded First Tr Enh New (FTSM)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Amgen (AMGN)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Anglogold Ashanti Com Shs (AU)
Cisco Systems (CSCO)
Packaging Corporation of America (PKG)
Darden Restaurants (DRI)

View all positions for Ellsworth Advisors

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Rubric Capital Management
Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Vanguard Group
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
Franklin Resources
Pivotal bioVenture Partners Investment Advisor
D. E. Shaw & Co

View all funds holding Arcutis Biotherapeutics